Amid a surge in Covid-19 cases across the country, fueled in large part by the spread of the new Omicron variant, at-home testing kits are nearly impossible to find in some areas. That makes the Biden administration’s new deal with a pharmaceutical company to increase production welcome news…except for one major catch.
The $137 million contract with Millipore Sigma, a unit of Germany’s Merck KGaA, to build a factory for making Covid-19 test strip materials won’t be ready for at least three years, the company said, according to Fox News, doing nothing to alleviate the current demand. The move also signals the virus will not be “shut down” by any politician, as Biden vowed on the campaign trail, but will be endemic.
Today, I committed $137 million to expanding the production of COVID-19 at-home tests using our military authority in order to meet demand. t.co/eNmA4CCkkR
— President Biden (@POTUS) December 30, 2021